HEALTH & LIFE SCIENCES NEWS
HEALTH & LIFE SCIENCES NEWS
Exploring Critical Business and Legal Issues across the Healthcare and Life Sciences Industries
HEALTH & LIFE SCIENCES NEWS
Exploring Critical Business and Legal Issues across the Healthcare and Life Sciences Industries

Michael Ryan Michael Ryan

Subscribe to Michael Ryan's Posts
Michael W. Ryan advises manufacturers, health care providers, developers, and investors on the legal, regulatory, and reimbursement issues that arise during the development and commercialization of medical devices, drugs, biological products, and clinical laboratory testing services. Read Michael Ryan's full bio.

Investing in Global Healthcare


By , , , , , , and on Jun 10, 2021
Posted In Digital Health, Health M&A, Health Private Equity, Life Sciences

Today’s global healthcare marketplace is marked by unprecedented transformation. This presents both challenges and opportunity to today’s market participants. We know how important it is to structure cross-border investments and transactions to account for complex and ever-shifting regulations. Within this dynamic environment, our health lawyers wield a deep knowledge of how healthcare services, medical technology...

Continue Reading



FDA 2019 Year in Review


By , , , and on Jan 13, 2020
Posted In FDA, Life Sciences

2019 was a robust year for the US Food and Drug Administration’s (FDA’s) regulatory agenda. The agency continued to implement initiatives and mandates required by the 21st Century Cures Act (Cures Act), and navigated leadership and staffing changes at many levels. Most notably, Commissioner Scott Gottlieb resigned on April 5. Norman Sharpless and Brett Giroir...

Continue Reading



STAY CONNECTED

TOPICS

ARCHIVES